Prevalence of NAFLD in T1DM Patients
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorZiekenhuis Oost-Limburg
About this trial
To determine the prevalence of NAFLD in T1DM patients.
Eligibility criteria
Qualifiers
T1DM
≥ 18 years of age
Written informed consent obtained
Disqualifiers
Excessive alcohol use
Exclusion of other causes of liver disease and secondary causes of liver steatosis
Trial design
Treatments tested in this trial
- FibroScan
Treatment groups
138 Participants
are divided into 1 treatment groupLocations
1Ziekenhuis Oost-Limburg3600, GenkLimburg, Belgium
Sponsors and collaborators
Ziekenhuis Oost-Limburg
Lead sponsor
Source ClinicalTrials.gov